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a  b  s  t  r  a  c  t
BACKGROUND:  Patient  Reported  Outcome  Measures  (PROMs)  assess  health  status  and health-related
quality  of life  from  the patient/service  user  perspective.  Our study  aimed  to:  i. develop  a PROM  for
recovery  from  drug  and  alcohol  dependence  that  has  good  face  and  content  validity,  acceptability  and
usability  for  people  in  recovery;  ii. evaluate  the  psychometric  properties  and  factorial  structure  of  the
new PROM  (‘SURE’).
METHODS:  Item  development  included  Delphi  groups,  focus  groups,  and  service  user feedback  on draft
versions  of  the  new  measure.  A  30-item  beta version  was completed  by  575  service  users  (461  in  per-
son  [IP]  and  114  online  [OL]).  Analyses  comprised  rating  scale  evaluation,  assessment  of  psychometric
properties,  factorial  structure,  and  differential  item  functioning.
RESULTS:  The  beta  measure  had  good  face  and  content  validity.  Nine  items  were  removed  due  to  low  stabil-
ity,  low  factor  loading,  low  construct  validity  or high  complexity.  The  remaining  21  items  were  re-scaled
(Rasch  model  analyses).  Exploratory  and  conﬁrmatory  factor  analyses  revealed  5 factors:  substance  use,
material resources,  outlook  on  life,  self-care,  and  relationships.  The  MIMIC  model  indicated  95%  metric
invariance  across  the  IP and  OL  samples,  and  100%  metric  invariance  for gender.  Internal  consistency  and
test-retest  reliability  were  granted.  The  5 factors  correlated  positively  with  the  corresponding  WHOQOL-
BREF  and  ARC  subscales  and  score  differences  between  participant  sub-groups  conﬁrmed  discriminative
validity.
CONCLUSION:  ‘SURE’  is  a psychometrically  valid,  quick  and  easy-to-complete  outcome  measure,  devel-
oped  with  unprecedented  input  from  people  in  recovery.  It  can  be  used  alongside,  or instead  of,  existing
outcome  tools.
©  2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. INTRODUCTION
The term ‘recovery’ is widely used within international addic-
tions literature, policy and practice (Center for Substance Abuse
∗ Corresponding author. Joanne Neale, National Addiction Centre, 4 Windsor Walk,
Institute of Psychiatry, Psychology & Neuroscience, King’s College London, Denmark
Hill, London, SE5 8AF, UK.
E-mail address: joanne.neale@kcl.ac.uk (J. Neale).
Treatment, 2006; Clark, 2008; Laudet, 2007, 2009; Scott and Dennis,
2002; White, 1996). Although the concept was once almost exclu-
sively associated with 12-step fellowships and abstinence (Laudet,
2009), there is growing recognition that recovery can be supported
by appropriately prescribed medications (Advisory Council on the
Misuse of Drugs, 2013; Recovery Orientated Drug Treatment Expert
Group, 2012; White, 2012; White and Mojer-Torres, 2010). Recov-
ery is also increasingly associated with achieving beneﬁts in a
wide range of life areas, including housing, health, employment,
offending, relationships, self-care, use of time, community partic-
http://dx.doi.org/10.1016/j.drugalcdep.2016.06.006
0376-8716/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Fig. 1. Item development and measurement evaluation.
ipation, and general well-being (Advisory Council on the Misuse
of Drugs, 2013; HM Government, 2010; Neale et al., 2012; The
Scottish Government, 2008). In 2009, Laudet identiﬁed a ‘critical’
need for an addiction recovery measure that would capture the
multi-dimensional nature of recovery and the views of multiple
stakeholder groups, including service users (Laudet, 2009).
Within many areas of medicine, assessment of patients’ views
of their own health status is considered essential for improving
the quality and cost effectiveness of services and interventions
(Dawson, 2009). This has resulted in the development of self-
completion questionnaires, rating scales and assessment forms,
known as patient reported outcome measures (or PROMs). PROMs
assess a patient’s health status or health-related quality of life at a
single point in time, give priority to the patient’s − rather than the
clinician’s − perspective, and focus on the quality rather than just
the quantity of life (Dawson, 2009). This is important since profes-
sionals’ assessments of patients’ treatment needs and health status
often differ from patients’ own assessments, and patients and pro-
fessionals may  disagree about the relative importance of speciﬁc
outcomes (Jenkinson, 1994; Neale et al., 2015; Rose et al., 2006;
Schwartz et al., 2005; Treloar et al., 2010).
Involving members of the target patient population in gener-
ating questions for a new PROM helps to ensure that the measure
developed captures all relevant concepts in a meaningful way and
that the questions asked are clear and interpretable (Neale et al.,
2015; Neale and Strang, 2015; Patrick et al., 2008). Engagement
of this kind is best achieved using qualitative methods such as
in-depth interviews, focus groups or other open consultation pro-
cesses (Lasch et al., 2010). After development, PROMs should be
subjected to rigorous psychometric testing to ensure that they are
reliable, valid, and measure health status and health-related out-
comes as objectively as possible (Dawson, 2009; Neale and Strang,
2015).
This paper reports on a study that had two  aims: i. to develop
a PROM for recovery from drug and alcohol dependence that has
good face and content validity, acceptability and usability for peo-
ple in recovery; ii. to evaluate the psychometric properties and
factorial structure of the PROM using suitable statistical techniques.
The PROM developed is inherently different from existing out-
come tools − such as the Addiction Severity Index (ASI; McLellan
et al., 1980), Opiate Treatment Index (OTI; Darke et al., 1992),
Maudsley Addiction Proﬁle (MAP; Marsden et al., 1998), Brief Treat-
ment Outcome Measure (BTOM; Lawrinson et al., 2005), Treatment
Outcomes Proﬁle (TOP; Marsden et al., 2008), and Addiction Dimen-
sions for Assessment and Personalised Treatment (ADAPT; Marsden
et al., 2014). It is the ﬁrst tool to focus speciﬁcally on the concept of
‘recovery’ and the only one developed with extensive service user
input. Reﬂecting this, it prioritises outcomes deemed important by
people in recovery (rather than clinicians or others) and is intended
for self-completion.
2. MATERIAL AND METHODS
The study received ethical approval from the UK  National
Research Ethics Service (reference number: 13/LO/1584). Study aim
i. (hereafter, ‘item development’) and study aim ii. (hereafter, ‘mea-
surement evaluation’) were each undertaken in stages (see Fig. 1).
2.1. Item development
Item development occurred between October, 2013 and
January, 2015. The demographic characteristics of the individu-
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als who participated in the various item development stages (25
service providers and 109 service users) are presented in Tables
S1-S4 in the supplementary materials. Participating service users
were recruited from across London, UK, and received a £15 voucher
in compensation for their time; participating service providers
received no ﬁnancial compensation. Throughout the development
process, the research team also received support and advice from
a separate project advisory group comprising 11 addiction service
users who were each paid £20 per consultation.
2.1.1. Stage 1. UK-based addiction psychiatrists, senior residential
rehabilitation staff and senior inpatient detoxiﬁcation staff (N = 25)
were asked to identify indicators of recovery in online Delphi
groups (Neale et al., 2014a). This had originally been intended as a
separate study but the indicators identiﬁed were so wide-ranging
that they provided a useful starting point for stage 2. At all subse-
quent developmental stages, service users were encouraged to add
new indicators.
2.1.2. Stage 2. Indicators of recovery identiﬁed by the 25 service
providers and the meaning of recovery more broadly were dis-
cussed within 5 focus groups of current and former drug and alcohol
service users (N = 44 service users in total) (Neale et al., 2015).
The research team discarded indicators that the focus group par-
ticipants described as irrelevant, inappropriate or offensive and
reworded indicators that group participants had deemed unaccept-
able due to terminology or language. The reworded indicators were
combined with indicators that group participants had generally
agreed were acceptable.
2.1.3. Stage 3. Members of the research team turned the revised
recovery indicators into recovery statements (candidate PROM
items)
2.1.4. Stage 4. Two further focus groups of current and former ser-
vice users debated and ranked the candidate PROM items, focusing
on wording, acceptability and importance. The research team then
analysed the focus group discussions to produce a draft measure,
which was discussed with members of the project advisory group.
2.1.5. Stage 5. A new sample of 18 current and former service users
completed the draft measure in person, commenting on wording,
content and form. The research team used the service user feedback
to generate a beta version of the measure, again in consultation with
the project advisory group.
2.1.6. Stage 6. A further 30 current and former services users com-
pleted the beta version of the measure in person, commenting on
the appropriateness and usefulness of the items, scaling system,
and layout. The research team analysed all feedback.
2.2. Measurement evaluation sample
Data collection for the measurement evaluation occurred
between February, 2015 and June, 2015.
2.2.1. In Person (IP) sample. Current and former service users
(N = 461) were recruited from community-based clinical services,
third sector services, and peer support services across London
(n = 329), Birmingham (n = 100) and West Sussex (n = 32), UK. These
individuals completed a questionnaire that comprised basic demo-
graphic, drug use and recovery questions and the recovery measure.
Participants were offered refreshments to compensate for their
time.
The ﬁrst 111 (London-based) participants additionally com-
pleted two validated measures: i. the WHOQOL-BREF − a quality of
life assessment (Skevington et al., 2004), and ii. the ARC − a scale
that assesses addiction recovery capital (Groshkova et al., 2013). Of
these 111 individuals, the ﬁrst 50 completed the questionnaire and
validated measures a second time, 2–7 days later. These 111 indi-
viduals received a £10 supermarket voucher for each questionnaire
completed.
2.2.2. Online (OL) sample. To expand the geographical reach of the
data collection, an online version of the demographic, drug use and
recovery questions and the recovery measure was  created using
the survey tool BOS (https://www.onlinesurveys.ac.uk/). The sur-
vey link was  emailed to 14 recovery-focused organisations based
across England and Scotland. No attempt was made to promote the
survey more widely and no compensation was  offered for com-
pleting the survey. In total, 114 individuals responded online from
across the UK.
The descriptive indices of the IP and OL samples are presented
and compared in Table 1.
2.3. Statistical analyses
The latent structure of the new measure was assessed via factor
analysis for categorical data using the weighted least squares esti-
mator (WLSMV; Muthén et al., 1997). The IP sample was randomly
divided into split half samples; the ﬁrst sub-sample was used in
exploratory factor analysis (EFA) and the second one in conﬁrma-
tory factor analysis (CFA) for categorical data. Both measures of
absolute and relative ﬁt were assessed, namely the relative chi-
square (relative 2: values close to 2 indicate close ﬁt; Hoelter,
1983), the Root Mean Square Error of Approximation (RMSEA,
values less than 0.8 are required for adequate ﬁt; Browne and
Cudeck, 1993), the Taylor-Lewis Index (TLI, values higher than 0.9
are required for close ﬁt; Bentler and Bonett, 1980) and the Com-
parative Fit Index (CFI, values higher than 0.9 are required for close
ﬁt; Bentler, 1990).
The adequacy of the rating scale was evaluated according to
the recommendations described by Linacre (2004), both within
each factor and for the complete set of items. Any item differential
functioning (DIF) with respect to the data source (IP vs OL) and gen-
der was assessed using multiple indicator multiple cause (MIMIC)
structural equation models (Muthén, 1985).
The reliability of the scale in terms of internal consistency was
evaluated using Cronbach’s (1951) alpha coefﬁcient. In terms of sta-
bility, test-retest reliability was assessed at item level using Cohen’s
(1968) weighted Kappa coefﬁcient () and at score level using the
intraclass correlation coefﬁcient (ICC; Koch, 1982).
Concurrent convergent validity was evaluated via correlations
with the WHOQOL-BREF and ARC subscale scores (Pearson’s r). Dis-
criminative validity was  assessed via score differences between
participant sub-groups based on their responses to demographic,
drug use and recovery questions in the questionnaire (t-test for 2
groups; one-way ANOVA for 3 or more groups).
Data analyses were conducted using R (R Core Team, 2013),
Facets (Linacre, 2015), and Mplus (Muthén and Muthén, 1998) sta-
tistical packages.
3. RESULTS
3.1. Item development outcome
In Stage 1, the online Delphi groups with service providers gen-
erated 76 indicators of recovery that comprised 15 broad domains
(Table S5; Neale et al., 2014a). The Stage 2 focus group participants
identiﬁed multiple problems with the 76 indicators, suggesting
that many were irrelevant, inappropriate, contradictory or offen-
sive (Neale et al., 2015). Indicators were discarded, reworded or
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Table 1
Descriptive indices by sample (in person vs online) and comparison.
In person Online Comparison
Gender
Males 333 (86%) 54 (14%) 2 df p-value
Females 128 (68%) 60 (32%) 25.68 1 <0.001
Age
Mean  43.0 44.7 t df p-value
SD  10.0 9.1 −1.680 572 0.093
Ethnicity
White  362 (76.4%) 112 (23.6%) 2 df p-value
Other  99 (98%) 2 (2%) 24.55 1 <0.001
Last  month
Main substance used: None 39 (9%) 38 (34%) 2 df p-value
Drugs  113 (25%) 38 (34%) 67.56 3 <0.001
Alcohol 209 (45%) 19 (17%)
Both  100 (22%) 16 (14%)
In  recovery (self-rated): No 54 (16%) 5 (4%) 2 df p-value
Yes  253 (72%) 97 (85%) 10.34 2 <0.001
Homeless: No 394 (90%) 110 (100%) 2 df p-value
Yes  67 (10%) 3 (0%) 11.96 1 0.001
In  paid legal work: No 406 (90%) 67 (60%) 2 df p-value
Yes  55 (10%) 45 (40%) 49.91 1 <0.001
In  residential treatment: No 317 (90%) 110 (100%) 2 df p-value
Yes  33 (10%) 3 (0%) 5.47 1 0.019
In  prison: No 339 (100%) 112 (100%) 2 df p-value
Yes  11 (0%) 0 (0%) 3.61 1 0.058
Prescribed OPTa: No 253 (50%) 104 (90%) 2 df p-value
Yes  208 (50%) 10 (10%) 51.90 1 0.001
Prescribed medication for alcohol dependenceb: No 331 (90%) 103 (90%) 2 df p-value
Yes  18 (10%) 10 (10%) 2.04 1 0.153
Lifetime:
Injected drug: No 300 (70%) 78 (70%) 2 df p-value
Yes  160 (30%) 36 (30%) 0.42 1 0.518
Attendance at mutual aid or support groups: No 216 (60%) 50 (40%) 2 df p-value
Yes  134 (40%) 63 (60%) 10.66 1 0.001
aRefers to opioid pharmacotherapy treatment: e.g., methadone, burprenorphine/Subutex, Suboxone, morphine sulphate or diamorphine.
bRefers to: acamprosate or naltrexone.
accepted accordingly, generating a new set of 33 recovery indi-
cators. In Stage 3, the 33 recovery indicators were turned into 33
recovery statements (candidate items) by members of the research
team (Table S6). Analyses from the two Stage 4 service user focus
groups resulted in further rewording of items, deletion of items and
the inclusion of some new items. This generated a draft recovery
measure comprising 30 items (Table S7).
In Stage 5, the researchers used feedback from the next sam-
ple of 18 current and former service users to amend the items
again, so generating a beta version of the measure (30 items across
8 domains) (Table S8). Each of the 30 items utilized a ﬁve-point,
ordinal (polytomous) rating scale, with scores ranging from 0-4,
except for the ﬁrst four items which were reversed scored (total
score range 0-120). An additional 8 questions at the end of the mea-
sure were not scored, but allowed individuals to rank each domain
on a four-point Likert scale for its importance to them personally.
In the ﬁnal development stage (Stage 6), 30 individuals com-
pleted the beta version recovery measure. In total, 29 (97%)
reported the measure was easy to complete, 28 (93%) reported it
was easy to understand, 25 (83%) reported the length was about
right, and 21 (70%) reported that it covered everything important.
Items that individuals identiﬁed as missing from the measure were
reviewed, but all had already been considered within the earlier
developmental stages and so were discounted. Time to complete
the measure ranged from 4–15 minutes. Fourteen individuals (47%)
volunteered that they had enjoyed completing it and none stated
that they had disliked completing it. All of the domains were con-
sistently ranked as ‘important’ or ‘very important’ by at least 28
(93%) participants. Good face and content validity, acceptability and
usability for people in recovery were conﬁrmed.
3.2. Measurement evaluation
3.2.1. Item reﬁnement. Using the 5-point (0-4) rating scale, Cohen’s
weighted  coefﬁcient was < 0.4 for 2 of the 30 items (‘I have abused
medication prescribed to me  by a doctor’ and ‘I have had enough
company and spent enough time with other people’). These two
items were therefore omitted from the measure on the grounds
of low stability (Landis and Koch, 1977). This resulted in a short-
ened 28-item recovery measure that was  used for the rating scale
evaluation.
Following Linacre (2004), we ﬁrst considered whether adjacent
categories in the rating scale needed to be combined. As Rasch anal-
ysis assumes unidimensionality, an initial exploratory factor model
was ﬁtted and this indicated ﬁve factors. Analyses of each of the ﬁve
factors and of the complete scale revealed that two pairs of cate-
gories (“0-1” and “3-4”) should be merged. This is illustrated in Fig. 2
which shows that, when ﬁve categories were used, the probability
of responding “0” was  higher than the probability of responding
“1” at the lower end of the latent trait even when category “1”
reached its peak. That is, at the point on the latent continuum where
category “1” occurred more often than at any other point, partici-
pants were still more likely to choose “0”, making the distinction
between the two response options redundant. Similarly, the prob-
ability of responding “4” was  always higher than the probability
of responding “3” at the higher end of the latent trait. This phe-
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Fig. 2. Category probabilities over the latent trait for the 5-point and for the 3-point rating scales.
nomenon is usually referred to as distorted thresholds (see Linacre,
2004 for details). In contrast, when a 3-point (1-3) rating scale was
used, there was a natural transition on the ordered categories in
terms of the amount of the latent trait (x-axis) and the probability
of choosing each category (y-axis).
The preliminary results were also used to omit items that: i.
showed low loadings across all factors; ii. reduced the alpha coef-
ﬁcient of the total scale or within a factor (low construct validity);
or iii. had very high loadings in multiple factors (high complexity)
(Table S9). These additional omissions produced a ﬁnal 21-item
measure. Service users in the project advisory group conﬁrmed
that the 21-item measure retained good face and content validity,
helped identify a name for the new measure, and facilitated wider
face-to-face and online consultation with service users to conﬁrm
the name: ‘Substance Use Recovery Evaluator’ or ‘SURE’. Full psy-
chometric assessment (reported below) was therefore undertaken
using the ﬁnal 21-item measure and a 3-point (1-3) rating scale.
3.2.2. Full assessment of psychometric properties.
3.2.2.1. Factor structure. Exploratory factor analysis for categori-
cal items was performed using a random half of the IP sample
(N = 231). The ﬁrst ﬁve eigenvalues were 9.6, 1.9, 1.5, 1.2, and 1.0.
The ﬁve-factor solution demonstrated close ﬁt to the data with
RMSEA = 0.046, relative 2 = 1.5 and RMSR = 0.041. Increasing the
number of factors resulted in similar ﬁt indices so, consistent with
the parsimony axiom, the ﬁve-factor solution was  accepted. Table 2
shows the loadings of the items on the factors (Promax rotation),
according to which the underlying dimensions were named: “sub-
stance use” (SU), “material resources” (MR), “outlook on life” (OK),
“self-care” (SC), and “relationships” (RE).
Conﬁrmatory factor analysis for categorical items was  next per-
formed using the second random half of the IP sample (N = 230).
The ﬁrst model implemented used the one factor solution to check
that the scale was not unidimensional. As anticipated, the one fac-
tor solution did not show close ﬁt to the data (relative 2 = 3.2, with
RMSEA = 0.098, TLI = 0.91, CFI = 0.92). In contrast, the EFA suggested
solution did demonstrate close ﬁt to the data (relative 2 = 1.7, with
RMSEA = 0.055, TLI = 0.97, CFI = 0.98). Thus, the 5-factor solution
suggested by the EFA was conﬁrmed by the CFA (CFA loadings are
presented in Table 2). The ﬁve-factor model also had close ﬁt in the
OL sample (RMSEA = 0.055, relative 2 = 1.3, TLI = 0.99, CFI = 0.99).
3.2.2.2. Differential item functioning. The next step in the analysis
was to test whether the model was invariant across the two  sam-
ples: IP and OL. The ﬁt of the MIMIC  model was adequate (relative
2 = 2.8, RMSEA = 0.057, TLI = 0.97, CFI = 0.98). Only one direct effect
was signiﬁcant: individuals who  completed the questionnaire OL
had increased probability of scoring higher in “managed pains and
ill health” than individuals who completed IP for the same levels of
recovery (effect = 0.536, se = 0.2, p = 0.014). These results indicated
metric invariance across the two groups for 95% of the items. For
the DIF assessment of gender, the complete sample (IP and OL)  was
used. With respect to gender, none of the direct effects was sig-
niﬁcant (100% metric invariance, relative 2 = 2.7, RMSEA = 0.055,
TLI = 0.98, CFI = 0.98).
3.2.2.3. Descriptive indices and associations with sample characteris-
tics. The descriptive indices for the ﬁve factors by gender and total
score (TS) are presented in Table 3. Females, scored higher than
males in the SU and MR  factors. In terms of differences between
the IP and OL samples, the OL sample scored signiﬁcantly higher in
all factors (p < 0.001 in all cases), adding up to a mean difference
of 8 units (s.e.=0.91) for the total score (t = 8.59, df = 573, p < 0.01).
The inter-correlations across the factors and total score were pos-
itive, signiﬁcant and moderate to strong (Table 4). Age correlated
weakly with the SU and MR  factors as well as with the total score,
indicating that individuals tended to have higher scores as age
increased.
3.3. Reliability
Cronbach’s alpha coefﬁcient was high in the IP sample
(alpha = 0.91), the OL sample (0.93) and when all individuals were
considered together (0.92), so indicating high internal consistency
of the items. No problematic items were found in terms of internal
consistency or low item-total correlations. The reliability coefﬁ-
cients were also satisfactory at factor level, albeit lower than for
the total questionnaire due to the small number of items in each
factor (Table 3).
When the test-retest analyses were repeated using the 3-point
(1-3) rating scale, Cohen’s weighted  coefﬁcient for all 21 items
varied from 0.4 to 0.8, representing ‘moderate to substantial agree-
ment’ according to Landis and Koch (1977). The ICC was  0.9 for the
total score and 0.6-0.8 for the ﬁve factors (Table S9). Additionally,
no signiﬁcant mean differences were found between the scores of
the factors or the total score, meaning that test-retest reliability
was granted for the ﬁnal 21-item measure (Table S10).
3.3.1. Validity. The correlations presented in Table 5 conﬁrm that
the 5 factors of the new recovery measure correlated positively
with the WHOQOL-BREF and the ARC subscale scores, demon-
strating appropriate concurrent convergent validity. Moreover, the
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Table 2
EFA loadings (Promax rotation) for the ﬁrst random half of the IP sample (N = 231) and CFA loadings (in parentheses) for the second random half of the IP sample (N = 230).a
No Item Substance Use (SU) Material Resources (MR) Outlook on Life (OK) Self-care (SC) Relationships (RE)
1 Drunk too much 0.79 (1.00) −0.30
2  Used street drugs 0.52 (1.13)
3  Had cravings 0.44 (1.16)
5  Coped with problemsb 0.93 (1.58)
7  Managed pains and ill healthb 0.77 (1.70)
16  Had non drug hobbies and interests 0.59 (1.78)
12  Had stable housing 0.62 (1.00)
13  Had a regular income 0.87 (1.02)
14  Been managing money 0.57 (0.91)
17  Felt happy with quality of life 0.90 (1.00)
18  Felt positive 0.94 (1.02)
19  Had realistic hopes and goals 0.66 (0.91)
4  Looked after mental health 0.48 (1.00)
6  Looked after physical health 0.66 (1.41)
8  Eaten a good diet 0.95 (1.18)
9  Slept well 0.44 (1.10)
15  Had a good daily routine 0.31 0.42 (1.44)
10  Got on well with people 0.45 (1.00)
11  Felt supported by people 0.40 0.43 (1.08)
20  Been treated with respect 0.82 (1.10)
21  Treated others with respect 0.57 (0.75)
a All loadings presented were signiﬁcant (p < 0.05).
b Without drugs or alcohol.
Table 3
Cronbach’s alpha coefﬁcient and score differences by gender.
a Females Males Complete Sample Comparison
Mean(Median) SD(min-max) Mean(Median) SD(min-max) Mean(Median) SD(min-max)
SU 0.83 13.5 (14) 3.6 (6-18) 12.7 (12) 3.5 (6-18) 13 (13) 3.6 (6-18) t = 2.57, df = 573, p = 0.010
SC  0.82 9.2 (9) 2.9 (5-15) 9.1 (9) 2.6 (5-15) 9.1 (9) 2.7 (5-15) t = 0.75, df = 573, p = 0.451
OK  0.87 5.1 (5) 1.8 (3-9) 5.3 (6) 1.8 (3-9) 5.2 (6) 1.8 (3-9) t = −1.19, df = 573, p = 0.235
RE  0.74 8.6 (8) 2.0 (4-12) 8.5 (8) 1.9 (4-12) 8.5 (8) 1.9 (4-12) t = 0.37, df = 573, p = 0.715
MR  0.68 7.5 (8) 1.5 (3-9) 6.7 (7) 1.8 (3-9) 7 (7) 1.7 (3-9) t = 5.27, df = 430*, p < 0.001
TSa 0.92 43.9 (44.5) 9.6 (24-63) 42.3 (42) 9.3 (22-63) 42.8 (43) 9.4 (22-63) t = 1.93, df = 573, p = 0.054
∗equal variances not assumed.
a Total Score.
Table 4
Factor, total score and age inter-correlations.
SU SC OK RE MR TS
SC 0.6 (<0.001)
OK 0.5 (<0.001) 0.7 (<0.001)
RE  0.5 (<0.001) 0.6 (<0.001) 0.6 (<0.001)
MR  0.5 (<0.001) 0.5 (<0.001) 0.4 (<0.001) 0.5 (<0.001)
TS  0.8 (<0.001) 0.9 (<0.001) 0.8 (<0.001) 0.8 (<0.001) 0.7 (<0.001)
Age  0.2 (<0.001) 0.1 (0.098) <0.1 (0.478) 0.1 (0.074) 0.2 (<0.001) 0.1 (0.003)
highest coefﬁcients emerged when the content of the scales were
matching.
In testing for discriminative validity, we found that people who
reported that they had been in paid work in the last month had
a signiﬁcantly higher total score on the 21-item recovery mea-
sure than those who said that they had not been in paid work (‘in
paid work’: mean = 45.9, sd = 9.6; ‘not in paid work’: mean = 42.1;
sd = 9.2, t = 3.70, df = 571, p < 0.001). People who reported that they
had been homeless in the last month had a lower total recovery
score than those who reported that they had not been home-
less (‘homeless’: mean = 36.5, sd = 8.3; ‘not homeless’: mean = 43.7,
sd = 9.2; t = −6.19, df = 572, p < 0.001). Additionally, people who
reported that had been in prison in the last month had a lower total
recovery score than those who reported that they had not been in
prison (‘in prison’: mean = 35.9, sd = 6.4; ‘not in prison’: mean = 43.5,
sd = 9.3; t = −2.68, df = 460, p = 0.008).
We also found signiﬁcant differences in mean total recovery
scores based on whether or not participants self-reported use
of any drugs or alcohol in the last year. Speciﬁcally, one way
ANOVA indicated that the total recovery score was  signiﬁcantly
higher (F[3,568] = 45.7, p < 0.001) for individuals who reported that
they had not used any substances (drugs or alcohol) (mean = 52.0,
sd = 6.7, N = 77), than for individuals reporting alcohol use only
(mean = 44.3, sd = 9.6, N = 151), individuals reporting drug use only
(mean = 40.3, sd = 8.3, N = 228), and individuals reporting both drug
and alcohol use (mean = 39.23, sd = 8.2, N = 116). According to the
Bonferroni adjustment for multiple comparisons, all pairwise mean
differences were signiﬁcant (p < 0.001 in all cases).
In terms of participants’ self-evaluation of their recovery sta-
tus (i.e., whether or not they currently considered themselves to
be ‘in recovery’), one way  ANOVA indicated that individuals who
reported that they were currently ‘in recovery’ scored signiﬁcantly
higher (mean = 45.2, sd = 9.1, N = 350) than those who  replied neg-
atively (mean = 38.1, sd = 8.2, N = 59) and those who were unsure
(mean = 37.3, sd = 7.3, N = 55; F[2,461] = 30.70, p < 0.001). According
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Table  5
Correlation coefﬁcients for the recovery measure scores and subscale scores of the WHOQOL-BREF and the ARC.a
SU  SC  OK  RE  MR  TS 
 Physical health 0.5  0.6  0.6  0.4  0.3 (0.004) 0.6  
 Psycho logica l healt h  0.5   0.7   0.7   0.6   0.4   0.7  
 Social health 0.4  0.4  0.5  0.5  0.2 (0.014) 0.5  
 Environ mental healt h  0.4   0.6   0.5   0.6   0.5   0.6  
 Total Physical Health 0.5  0.6  0.6  0.4  0.3 (0.004) 0.6  
 Total Psycho logica l Healt h  0.5   0.7   0.7   0.6   0.4   0.7  
 Total Social Healt h  0.4   0.4   0.5   0.5   0.2 (0.014 )  0.5  
W
H
O
Q 
(N
=1
11
) 
 Total Environ mental Healt h  0.4   0.6   0.5   0.6   0.5   0.6  
Sub stance  use and  sob riety  0.6   0.5   0.5   0.4   0.2 (0.029 )  0.6  
Glob al psycho logica l healt h  0.5   0.7   0.7   0.5   0.4   0.7  
Glob al ph ysica l healt h  0.5   0.6   0.6   0.4   0.2 (0.047 )  0.6  
Citize nship and  communit y 
involvement 0.4   0.4   0.4   0.3 (0.003 )  0.4   0.4  
Social suppo rt  0.5   0.6   0.6   0.6   0.5   0.7  
Meaningful activities 0.5  0.6  0.6  0.5  0.4  0.7  
Hou sing and  safety  0.4   0.4   0.5   0.5   0.5   0.5  
Risk taking  0.4   0.5   0.4   0.5   0.5   0.6  
Cop ing and  li fe fun ction ing  0.5   0.7   0.6   0.6   0.5   0.7  
A
R
C
 
(N
=1
11
) 
Rec overy experience   0.5   0.4   0.4   0.5   0.5   0.6  
a Grey values correspond to non-signiﬁcant correlations after adjusting for multiple comparisons (p-value within parenthesis); for the remaining coefﬁcients, the p-value
was  <0.001.
to the Bonferroni adjustment for multiple comparisons, all pairwise
mean differences were again signiﬁcant (p < 0.001 in all cases).
4. DISCUSSION
Extensive developmental work, comprising qualitative and
quantitative methods, with signiﬁcant input from service users,
was undertaken to develop items for ‘SURE’, a new PROM for
recovery from drug and alcohol dependence. The ﬁnal measure
comprises 21 items and 5 factors: “substance use” (6 items), “mate-
rial resources” (3 items), “outlook on life” (3 items), “self-care” (5
items) and “relationships” (4 items). Members of a service user
project advisory group conﬁrmed face and content validity and
service users helped to determine the name of the new measure.
Analyses established the measure’s factor structure, invariance,
reliability and validity. SURE is distinct from other addiction
outcome measures given its focus on ‘recovery’, and overall pri-
oritisation of the service user perspective in both its development
and intended use.
The ﬁve factors identiﬁed are consistent with a concept of recov-
ery that encompasses a range of life areas (Advisory Council on the
Misuse of Drugs, 2013; HM Government, 2010; Neale et al., 2012;
The Scottish Government, 2008). Only 6/21 items explicitly refer
to substance use, highlighting how it is possible to be in ‘recovery’,
despite some drinking or drug taking. This reﬂects the more inclu-
sive (non-abstinence) approach to recovery that has gained traction
in recent years (Duke et al., 2013; Recovery Orientated Drug Treat-
ment Expert Group, 2012). That there is no standalone employment
item is also notable given the UK Government’s repeated emphasis
on drug users having to secure paid work (Department for Work
and Pensions, 2015; Home Ofﬁce, 2008; The Scottish Government,
2008). Instead, ‘SURE’ has an item that refers to ‘having a regular
income (from beneﬁts, work or other legal sources)’, and a related
item on ‘having a good daily routine’. These alternative indicators
implicitly acknowledge that individuals may  not be able to secure
paid work for structural reasons unrelated to personal recovery
(e.g., lack of jobs or employers’ lack of willingness to employ people
with a history of substance use or related criminal activity) (Kemp
and Neale, 2005) and that stability and having meaningful activity
are more valid indicators of recovery.
Each of the ﬁve factors is internally coherent. For example, the
6 substance use items are the only items that explicitly refer to
drinking or drug use and the four relationship items are the only
four that explicitly relate to ‘people’. The only factor that did not
correlate signiﬁcantly with the WHOQOL-BREF and the ARC was
‘material resources’. This warrants consideration. Previous quali-
tative research (Neale et al., 2012, 2014b) and the focus groups
we conducted in developing the measure (Neale et al., 2015) have
found that people in recovery want stable housing, regular income
and money to pay bills. However, they do not generally covet mate-
rial good or wealth because i. disposable income can become a
temptation to buy drugs or alcohol and ii. they tend to prioritise
relationships and people over possessions. This may help to explain
why our 3 material resource items correlated well with recovery in
general, but less well with substance use, and other general quality
of life indicators.
‘SURE’ items are completed using a 5-point rating scale, but
scored using a 3-point scale (the two  categories at the lower end of
the latent trait are combined, as are the two  categories at the higher
end of the latent trait). Total ‘SURE’ scores therefore range from 21-
63. The 5-point scale has been retained for completion purposes
because: i. service users repeatedly told us that they liked having
ﬁve options to consider; ii. it is not difﬁcult to re-score the items
post completion; and iii. we  noticed that service users complet-
ing the measure often paused thoughtfully when deciding how to
respond to the ﬁve categories, and then spontaneously discussed
their thoughts with the researcher. As we have previously argued
(Neale and Strang, 2015), completion of the PROM seldom simply
generated a numeric score. Rather, it prompted people to reﬂect on
and volunteer potentially valuable contextual information about
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their lives and circumstances that might be relevant in a therapeutic
context.
As with all new measures, there are limitations. First, we
note that ‘SURE’ is not tailored for use in residential settings
(e.g., residential detoxiﬁcation, residential rehabilitation or prison).
Although we included residential treatment clients in our develop-
mental work to ensure that their views were captured, service user
feedback indicated that several items were difﬁcult for residential
clients to answer. This is because responses to items such as ‘eaten a
good diet’, ‘having stable housing’, ‘having a good daily routine,’ and
‘managing money’ tend to be affected by the structure and routine
of the residential setting and so beyond individual control. Service
users living in residential settings were therefore not included in
the sample used for the measurement evaluation. Second, addi-
tional validity testing (e.g., criterion or predictive validity) would
be desirable. Third, language and terminology are historically and
culturally sensitive. The wording of items in ‘SURE’ (particularly
those relating to substance use) need to be carefully reviewed to
ﬁnd culturally appropriate terms if the measure is to be used in
other countries.
In contrast, ‘SURE’ has a number of signiﬁcant strengths. First,
service users have played a fundamental role in its design and con-
tent, and it is found to have good face validity. This level of service
user engagement is unprecedented in any existing validated addic-
tion outcome measure. Second, the measure has been designed by a
careful and considered blending of qualitative methods (with their
focus on subjective meaning and understanding) and more objec-
tive quantitative techniques. This capitalises on the strengths of
each to ensure a robust development and validation process. Third,
the study participants were diverse in terms of age, ethnicity, drugs
used, and geographical location, thus providing reassurances in
terms of inclusion and diversity. Fourth, the measure retains ﬁve
unscored questions at the end that encourage participants to reﬂect
on how important each of the factors is to them personally. Service
users liked this ﬁnal component. As a member of the advisory group
explained: “I like the way that it ends. . . this part reinforces that
the service user has a big part to play; that this is what’s important
to them as individuals”.
‘SURE’ is a psychometrically valid, quick and easy-to-complete
measure, developed with signiﬁcant input from people in recov-
ery. It can be used by individuals to monitor and reﬂect on their
own recovery journeys, either in private or in the context of a
therapeutic relationship. It can also be used to assess treatment
outcomes at a service level or by researchers seeking to evalu-
ate new interventions. As such it can be used either alongside,
or instead of, existing outcome tools. In the coming months we
will continue our work by exploring opportunities for develop-
ing online and app versions with an integrated scoring system
and graphical displays; collecting longitudinal data to test for
predictive validity; seeking collaborators for international valida-
tion; and adapting the methodology for other drug and alcohol
related PROMs, PREMs (Patient Reported Experience Measures) and
CROMs (Carer Reported Outcome Measures).
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